Harrisburg, NC -- (SBWIRE) -- 10/11/2018 -- United States Insulin Pump Market is expected to reach US$ 3.8 Billion by the year end of 2022.
Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pump devices is expected to hamper growth of the market during forecast period.
Buy complete research data at:
This is the 2nd latest edition report published by the Market Report Publisher. "United States Insulin Pump Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022" provides a deep and thorough evaluation of the United States Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users. Market outlook in value terms has been analysed based on current and potential trends and the market is estimated from 2017 to 2022. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market.
The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation and Tandem Diabetes Care. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.
For More Details Inquire at:
Key Topics Covered in the Report
United States Diabetes Population (2011 - 2022)
United States Insulin Pump Users and Market Analysis (2011 - 2022)
United States Insulin Pump Preferred Brand - By Product
United States Insulin Pump Market: Reimbursement & Regulation System
United States Insulin Pump Market - Major Deal Types
Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
Key Companies Analysis
Key Drivers and Inhibitors of the United States Insulin Pump Market
Key Companies Covered in the Report are as follows:
Animas Corporation and
Tandem Diabetes Care
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Browse Full Report at:
Reasons to Purchase this Report
- Identify the current and future prospect of the Insulin Pump market in the developed and emerging markets
- Analyze various perspectives of the market with the help of Porter's five forces analysis
- Information about the growth of the various material, type, and application that are expected to dominate the market
- Regional and country analysis of the market
- Identify the latest developments, market shares, and strategies employed by the major market players
- 3 months analyst support, along with the Market Estimate sheet (in Excel)
About Us: -
MarketInsightsReports provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. These reports include in-depth market research studies i.e. market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
+1 (704) 266-3234 |firstname.lastname@example.org
Connect with us on: